Lupus patients have been waiting a while for some good news. Only one drug, belimumab (Benlysta), has been FDA-approved for lupus in more than 50 years — and that happened…
"Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.” In 2017, tocilizumab (Actemra), a biologic drug that inhibits interleukin-6 (IL-6), was FDA-approved for giant cell…
Some people with rheumatoid arthritis (RA) take a disease-modifying antirheumatic drug (DMARD) and/or a biologic and reach remission. Others try drug after drug after drug and never find one that’s…
The anti-malarial drug lowers cholesterol and blood sugar makes blood less sticky, which is good for reducing blood clots and heart attack risk. If you take the anti-malarial drug hydroxychloroquine…
Screening is important because silent hepatitis B and C infections can spring to life when you start biologics or new synthetic DMARDs. Before you start taking a biologic drug or…
A new study adds support to the theory that psychological stress might increase the risk of fibromyalgia and make symptoms worse. No one knows what causes fibromyalgia but some experts…
Osteoarthritis is the most common and well-known type of arthritis. It’s largely a wear-and-tear form of arthritis that happens as a result of damage to or overuse of a joint,…
As the temperature increased, so did the risk of rash, joint inflammation, kidney problems, and other lupus symptoms. Shifts in weather patterns have long been associated with a variety of…
Researchers hope that identifying the link between respiratory issues and RA will result in better ways to prevent or screen for rheumatoid arthritis in people with lung disease. You may…
New data compares what happens when the dosage of DMARDs such as methotrexate is tapered or kept steady. For most rheumatoid arthritis (RA) patients, sustained remission (inactive disease) is the…